Related Experiment Video
Updated: Jun 2, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
68
Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy
Seyed Reza Taha1,2, Mehdi Karimi3, Bahar Mahdavi4
1Department of Pathology and Immunology, Washington University School of Medicine, St. LouisWashington, MO, USA.
Epigenetics & Chromatin
|January 14, 2025
Summary
Non-coding RNAs (ncRNAs) significantly regulate programmed cell death (PCD) in colorectal cancer (CRC), impacting tumor progression and treatment resistance. Targeting ncRNA-PCD interactions offers new therapeutic strategies for CRC.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
- CRC progression involves complex genetic, epigenetic, and environmental interactions.
- Non-coding RNAs (ncRNAs) regulate gene expression and programmed cell death (PCD) in biological processes.
Purpose of the Study:
- To review the role of ncRNAs in regulating PCD in CRC.
- To explore how ncRNAs influence cancer cell survival, proliferation, and treatment resistance.
- To identify ncRNAs as potential biomarkers and therapeutic targets in CRC.
Main Methods:
- Comprehensive literature analysis of recent findings.
- Examination of ncRNAs modulating apoptosis, autophagy, necroptosis, and pyroptosis.
- Assessment of ncRNA impact on CRC development and therapeutic response.
Main Results:
- ncRNAs significantly regulate PCD pathways in CRC.
- ncRNA influence affects tumor growth, metastasis, and treatment sensitivity.
- ncRNAs show potential as biomarkers for early detection and therapeutic targets.
Conclusions:
- ncRNAs are key regulators of PCD in CRC biology.
- Targeting ncRNA-PCD interactions offers novel therapeutic strategies.
- Modulating ncRNAs may improve CRC patient outcomes through enhanced treatment efficacy and reduced resistance.
Related Concept Videos
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K